Literature DB >> 21948056

Myotonic dystrophy type 2 and autoimmune chronic gastritis: an incidental association?

Francesco Sicurelli, Andrea Mignarri, Rosanna Cardani, Mauro Mondelli, Alessandra Carluccio, Daniela Marino, Giovanni Meola, Antonio Federico, Maria Teresa Dotti.   

Abstract

Entities:  

Mesh:

Year:  2011        PMID: 21948056     DOI: 10.1007/s10072-011-0782-2

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


× No keyword cloud information.
  4 in total

1.  Autoantibodies to parietal cells as predictors of atrophic body gastritis: a five-year prospective study in patients with autoimmune thyroid diseases.

Authors:  Renato Tozzoli; Graziano Kodermaz; Anna Rosa Perosa; Marilina Tampoia; Antonietta Zucano; Antonio Antico; Nicola Bizzaro
Journal:  Autoimmun Rev       Date:  2010-08-06       Impact factor: 9.754

2.  Myotonic dystrophy type 2: molecular, diagnostic and clinical spectrum.

Authors:  J W Day; K Ricker; J F Jacobsen; L J Rasmussen; K A Dick; W Kress; C Schneider; M C Koch; G J Beilman; A R Harrison; J C Dalton; L P W Ranum
Journal:  Neurology       Date:  2003-02-25       Impact factor: 9.910

3.  Strong association between myotonic dystrophy type 2 and autoimmune diseases.

Authors:  A A Tieleman; A A den Broeder; A-E van de Logt; B G M van Engelen
Journal:  J Neurol Neurosurg Psychiatry       Date:  2009-11       Impact factor: 10.154

4.  Gastrointestinal involvement is frequent in Myotonic Dystrophy type 2.

Authors:  Alide A Tieleman; Judith van Vliet; Jan B M J Jansen; Anneke J van der Kooi; George F Borm; Baziel G M van Engelen
Journal:  Neuromuscul Disord       Date:  2008-07-07       Impact factor: 4.296

  4 in total
  1 in total

1.  Autoimmune Diseases in Patients With Myotonic Dystrophy Type 2.

Authors:  Stojan Peric; Jelena Zlatar; Luka Nikolic; Vukan Ivanovic; Jovan Pesovic; Ivana Petrovic Djordjevic; Svetlana Sreckovic; Dusanka Savic-Pavicevic; Giovanni Meola; Vidosava Rakocevic-Stojanovic
Journal:  Front Neurol       Date:  2022-07-18       Impact factor: 4.086

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.